Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÆÄÁö µð½ºÇ÷¹À̸¦ ÀÌ¿ëÇÑ ÃéÀå¾Ï ƯÀÌÀû °áÇÕ ÆéŸÀÌµå °³¹ß Development of a Pancreatic Cancer Specific Binding Peptide Using Phage Display

´ëÇѼÒÈ­±âÇÐȸÁö 2019³â 74±Ç 1È£ p.30 ~ 41
À̵¿¿ø, ¹ÚÀç¸í, ¾ç½Â¸ñ, °û¹®È­, ³ëÀ±Áø, ÀÌÀμ®, ÃÖ¸í±Ô,
¼Ò¼Ó »ó¼¼Á¤º¸
À̵¿¿ø ( Lee Dong-Won ) 
°¡Å縯±¤ÀÇÇבּ¸¼Ò

¹ÚÀç¸í ( Park Jae-Myung ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¼º¸ðº´¿ø ³»°ú
¾ç½Â¸ñ ( Yang Seung-Mok ) 
°¡Å縯±¤ÀÇÇבּ¸¼Ò
°û¹®È­ ( Kwak Moon-Hwa ) 
°¡Å縯±¤ÀÇÇבּ¸¼Ò
³ëÀ±Áø ( Roh Yoon-Jin ) 
°¡Å縯±¤ÀÇÇבּ¸¼Ò
ÀÌÀμ® ( Lee In-Seok ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¼º¸ðº´¿ø ³»°ú
ÃÖ¸í±Ô ( Choi Myoung-Gyu ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¼º¸ðº´¿ø ³»°ú

Abstract


Background/Aims: Pancreatic cancer has a very poor prognosis, and early diagnosis is a way to increase the survival rate of patients. The purpose of this study was to develop pancreatic cancer-specific peptides for imaging studies.

Methods: Three pancreatic cancer cell lines, MIA PaCa-2, UACC-462, and BxPC-3, and a control cell line, CCD841, were used. Biopannings were performed on MIA PaCa-2 using a phage display library. After this, the peptides were synthesized and labeled with fluorescein isothiocyanate (FITC). Immunocytochemistry (ICC), enzyme-linked immunosorbent assay (ELISA), and fluorescence- activated cell sorter (FACS) were performed to examine the specific binding. To examine its therapeutic applications, a photosensitizer, chlorin e6 (Ce6), was conjugated on the peptide and photodynamic therapy was performed. Cell survival was investigated using a [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] assay.

Results: After three biopannings, the phages were amplified from 1.4¡¿104 to 3.2¡¿105 plaque-forming units. The most strongly binding phage was selected from the ELISA and ICC results. FITC-labeled peptide, M5, in the three pancreatic cancer cell lines showed significantly higher immunofluorescence in the ICC experiments than that of CCD841. The higher binding ability to MIA PaCa-2 cells was confirmed from FACS analysis, which showed a right shift compared to CCD841. M5 bound to Ce6 showed a significantly lower cell survival rate than that of Ce6 alone in photodynamic therapy, which was observed consistently as a change in the tumor size and fluorescence intensity in MIA PaCa-2 cell-implanted animal models.

Conclusions: This study showed that the noble peptide, M5, binds specifically to the pancreatic cancer cell line, MIA PaCa-2. The M5 peptide has potential use in future optical diagnostic and therapeutic purposes.

Å°¿öµå

Bacteriophages; Pancreatic neoplasms; Peptides; Photochemotherapy

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS